Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021
Jefferson M. Jones, Jean D. Opsomer, Mars Stone, Tina J. Benoit, Robyn Ferg, Susan L. Stramer, Michael P. Busch
Abstract
1.21-2.18), and 0.37 vs 0.16 for diagnoses on hospital day 15 or later (RR, 2.31; 95% CI, 1.53-3.49). The increase in hospital-onset infections during the Omicron wave vs the prior winter wave mirrored similar increases in community and health care worker case numbers during these same periods (Figure).
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)SeroprevalenceCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBlood donationsVirologyCoronavirus InfectionsImmunologyHuman immunodeficiency virus (HIV)Internal medicineOutbreakAntibodySerologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction